Characteristics of submucosal leiomyomas that could cause severe hemorrhage with relugolix: an observational study.

Wada, Yoshimitsu; Takei, Yuji; Minezumi, Takumi; Hirashima, Hiroto; Fujiwara, Hiroyuki

Wada, Yoshimitsu; Takei, Yuji; Minezumi, Takumi; Hirashima, Hiroto; Fujiwara, Hiroyuki.

Afiliación

Wada Y; Department of Obstetrics and Gynecology, Sano Kosei General Hospital, 1728 Horigome, Sano, Tochigi, 327-8511, Japan.
Takei Y; Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Minezumi T; Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. ytakei@jichi.ac.jp.
Hirashima H; Department of Obstetrics and Gynecology, Sano Kosei General Hospital, 1728 Horigome, Sano, Tochigi, 327-8511, Japan.
Fujiwara H; Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.

BMC Womens Health ; 23(1): 110, 2023 03 15.

Article en En | MEDLINE | ID: mdl-36922784

Asunto(s)

Leiomioma; Neoplasias Uterinas; Femenino; Humanos; Embarazo; Leiomioma/complicaciones; Leiomioma/cirugía; Compuestos de Fenilurea/uso terapéutico; Estudios Retrospectivos; Neoplasias Uterinas/complicaciones; Neoplasias Uterinas/cirugía

Palabras clave

Adverse events; Gonadotropin-releasing hormone receptor antagonist; Relugolix; Submucosal leiomyoma; Uterine hemorrhage; Uterine leiomyoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Leiomioma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: BMC Womens Health Asunto de la revista: SAUDE DA MULHER Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google